Commentary|Articles|March 6, 2024
Diversity in Clinical Trials: The Need to Take Action
Author(s)Andy Studna, Senior Editor
Gadi Saarony, CEO of Advarra discusses the current state of diversity in clinical trials and how industry needs to be more proactive in addressing it.
Advertisement
Gadi Saarony, CEO of Advarra examines the current state of diversity in clinical research. He discusses the need for industry to take more action in making trials more diverse, what regulatory bodies need to do to increase awareness, and how researchers can best reach diverse populations.
About the speaker
Gadi Saarony, CEO of Advarra has over 25 years of leadership experience, including commercial and operational clinical research roles. Prior to joining Advarra, he served as Executive Vice President and Chief Clinical Research Services Officer at Parexel where he was responsible for operational delivery of company research services such as patient recruitment and data management.
Gadi Saarony, CEO of Advarra has over 25 years of leadership experience, including commercial and operational clinical research roles. Prior to joining Advarra, he served as Executive Vice President and Chief Clinical Research Services Officer at Parexel where he was responsible for operational delivery of company research services such as patient recruitment and data management.
About the ACT Podcast
The editors of Applied Clinical Trials bring you the latest commercial insights to master the science of success. Podcast episodes examine current trends, key conferences, and critical topics in the bio/pharmaceutical industry.
Listen to this podcast on Spotify and Google Podcasts
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025
- Ensuring Digital Trial Platforms Work for Underserved Communities
September 10th 2025
- Why Decentralized Trials Face Slow Adoption Despite Strong Data
August 26th 2025
- DEI & Clinical Trials: Navigating Policy Shifts
August 22nd 2025
Advertisement
Advertisement